Stanford researchers develop a machine-learning computer model for mammography assessment in hopes of aiding radiologists’ clinical decisions.
In this In the Spotlight Q&A, radiology instructor Ahmed Nagy El Kaffas shares how a best friend and a trip to China shaped his early career.
A Stanford study shows Pokémon expertise developed during childhood activates the brain region that processes information from the center of the retina.
If physicians follow the guidelines for patients with leg and lower back pain and wait before getting MRIs, it could save half a billion dollars a year.
Small trial conducted by Stanford researchers links activity in the brain's reward processing system with drug relapse in patient cohort.
Researchers led by Daniel Palanker have discovered that an imaging technique known as interferometry could be used to monitor neuron behavior.
Scientists modify a well-established imaging technique using gold nanoparticles to see swaths of tissue at a single-cell level.
Stanford engineer Ellen Kuhl is using computer modeling to provide insight into the progress of neurodegenerative diseases like Alzheimer's.
Stanford innovators have created ways to fit MRI scanning equipment to kids instead of the other way around. Adult patients can benefit, too.
A new imaging technology that harnesses fluorescence allows scientists to detect tuberculosis in an hour and to measure drug efficacy.
A recent lecture by clinician-researcher Daniel Bernstein highlighted an imaging technique for assessing the diverse ways mitochondria behave within heart cells.
Researchers have used an ultrafast, intense X-ray laser to observe how Mycobacterium tuberculosis bacteria attack antibiotics, making the drugs ineffective.
Scientists at Stanford have created a new PET scan-compatible tracing agent that tracks immune cells poised to attack cancer, offering a new way to predict the success of certain therapies.
Clinicians now have up to 24 hours to treat a stroke, thanks in part to research and tools developed at Stanford Medicine.
A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.
Stanford's Mary Leonard has devoted her research career to understanding how chronic diseases weaken children's bones, and what we can do about it.